Inhibition of the hedgehog pathway leads to antifibrotic effects in dermal fibrosis

Autor(en): Cao, H.-L.
Zhou, J.
Chen, X.-B.
Landeck, L.
Yang, J.-Q.
Chen, J.-Q.
Li, W.
Cai, S.-Q.
Zheng, M.
Man, X.-Y.
Stichwörter: bleomycin, 11056-06-7, 9041-93-4; collagen, 9007-34-5; cyclopamine, 4449-51-8; mitogen activated protein kinase, 142243-02-5; mitogen activated protein kinase 1, 137632-08-7; mitogen activated protein kinase 3, 137632-07-6; Smad2 protein, 253862-89-4; sodium chloride, 7647-14-5; Bleomycin; cyclopamine; Hedgehog Proteins; Repressor Proteins; SUFU protein, human; Veratrum Alkaloids; bleomycin; collagen; cyclopamine; lentivirus vector; mitogen activated protein kinase; mitogen activated protein kinase 1; mitogen activated protein kinase 3; Smad2 protein; sodium chloride; sonic hedgehog protein; transforming growth factor beta1; bleomycin; cyclopamine; repressor protein; sonic hedgehog protein; SUFU protein, human; Veratrum alkaloid, animal experiment; animal model; animal tissue; Article; cell migration; controlled study; fibroblast culture; gene overexpression; histopathology; human; human tissue; immunoblotting; Lentivirus infection; mouse; nonhuman; real time polymerase chain reaction; RNA extraction; skin fibroblast; skin fibrosis; skinfold thickness; systemic sclerosis; upregulation; Western blotting; wound healing; animal; C57BL mouse; cell motion; chemically induced; disease model; drug effects; fibrosis; genetics; in vitro study; metabolism; pathology; phosphorylation; skin; skin disease, Animals; Bleomycin; Cell Movement; Disease Models, Animal; Fibrosis; Hedgehog Proteins; Humans; Immunoblotting; In Vitro Techniques; Mice; Mice, Inbred C57BL; Phosphorylation; Real-Time Polymerase Chain Reaction; Repressor Proteins; Skin; Skin Diseases; Veratrum Alkaloids
Erscheinungsdatum: 2016
Herausgeber: Solariz, Inc.
Enthalten in: Discovery Medicine
Band: 22
Ausgabe: 122
Dermal fibrosis is characterized by the activation of the matrix-producing 'positive' myofibroblasts, and the relentless production and deposition of extracellular matrix. The hedgehog pathway has recently been demonstrated to work in a pro-fibrotic manner in systemic sclerosis (SSc). A negative regulator of the hedgehog pathway (Hh), the suppressor of fused (Sufu), was shown to be involved in the activation of fibrotic diseases. However, the exact role of Sufu in fibrosis has not been investigated so far. In our study, we aimed to define the role of sufu in the process of fibrosis using dermal fibroblasts of healthy donors that were cultured in vitro. Cyclopamine, a Smo antagonist, and Sufu lentivector were used to treat or transfect cells. The expression of fibrosis markers and ERK1/2, Smad2, and GSK3β at the protein level was determined by Western blot. Fibroblast migration was measured by in vitro wound healing assay. Bleomycin-induced dermal fibrosis mouse model was introduced to assess the effect of cyclopamine on dermal fibrosis in vivo. We found that cyclopamine significantly upregulated the expression of Sufu. Both cyclopamine and Sufu lentivector reduced migration and myofibroblast differentiation of human dermal fibroblasts at a statistically significant level. Furthermore, cyclopamine reversed dermal fibrosis induced by TGF-β1. Cyclopamine and the overexpression of Sufu inhibited the phosphorylation of GSK-3β and restrained the migration of fibroblasts. Dermal fibrosis was inhibited by intraperitoneal injection of cyclopamine in a mouse model of scleroderma. Our findings suggest that cyclopamine and Sufu-overexpression may effectively inhibit the endogenous as well as the TGF-β1-induced activation of fibroblasts through subsequent activation of GSK-3β. Sufu agonists may be a promising approach in the development of antifibrotic medications for dermal fibrosis and systemic sclerosis. © 2016, Discovery Medicine. All Rights Reserved.
ISSN: 15396509
Externe URL:

Show full item record

Page view(s)

Last Week
Last month
checked on Jun 15, 2024

Google ScholarTM